is mounjaro glp 1 agonist Tirzepatide (Mounjaro) Mounjaro (Tirzepatide): Raising the Bar
Description
Minis E, Stanford FC, Mahalingaiah S

Ongoing research efforts into this variant aim to uncover the molecular factors associated with its benefits, focusing on the analysis of transducer factor recruitment and receptor trafficking patterns in response to a range of clinical and non-clinical GLP-1RAs

It can be observed that proglucagon is not expressed by a single gene, but is embedded in a larger gene, and when this large gene expresses a large peptide chain (called preprohormones), it is then cleaved by specific enzymes and post-translationally modified to finally obtain fragments with different biological activities
doi:10.1186/s12884-024-06899-w

2024;16(11):e74321

The shedding often becomes noticeable two to four months after starting treatment or after significant weight loss, which is a key distinguishing feature